Following as we in CT are updating processes as well.
Thank you.
Regina Ali, BSN, RN, BC
Colleague Health Nurse Manager
Central Region
Hartford HealthCare
Colleague Health Services
100 Grand Street, New Britain, CT 06050
435 Lewis Ave, Meriden, CT 06450
P: 860-224-5605
C: 203-687-8527
F: 860-224-5745
This e-mail message, including any attachments, is for the sole use of the intended recipient(s) and may contain confidential
and privileged information. DO NOT FORWARD THIS E-MAIL. Any unauthorized review, use, disclosure, or distribution is prohibited. If you are not the intended recipient, or an employee or agent responsible for delivering the message to the intended recipient,
please contact the sender by reply e-mail and destroy all copies of the original message, including any attachments.
From: MCOH-EH <mcoh-eh-bounces@mylist.net> On Behalf Of
David S. Cockrum via MCOH-EH
Sent: Wednesday, March 26, 2025 2:55 PM
To: MCOH-EH <mcoh-eh@mylist.net>
Cc: David S. Cockrum <David.S.Cockrum@hitchcock.org>
Subject: [MCOH-EH] Urine Drug Screen Tested Drugs
This is sort of a cross-over MRO question (but I’ve somehow disconnected from the MRO listserv) but is also related to my role as Medical Director of Employee Health
and Wellness. We have recently discovered that some of our remote employees
This is sort of a cross-over MRO question (but I’ve somehow disconnected from the MRO listserv) but is also related to my role as Medical Director of Employee Health and Wellness.
We have recently discovered that some of our remote employees live in states that require employers to specifically name the drugs that are being tested during pre-employment. Local pre-employment evals are tested with a standard 12-panel
which we mimic as close as we can through the collection site/commercial lab nearest the candidate, but sometimes these are 10 panels, 9 panels, or whatever.
I am being asked to come up with a list of “must test” drugs that we can have in policy. Including the SAMHSA 5 (federal 5, DOT 5, or whatever you want to call them) is definitely a starting point. Was wondering if anyone has a reference
for this, or experience. It seems the most common drug not included in panels is buprenorphine – I wouldn’t mind not including it in our list, but I need to understand risk of abuse to ensure we don’t overlook potential for patient harm, etc.
Appreciate any thoughts, and if anyone has the MRO list info, please share that with me (david.s.cockrum@hitchcock.org) so I can post there as well.
Thanks,
David
David S. Cockrum, MD, MPH
He/Him/His
Medical Director & Section Chief
Occupational & Environmental Medicine
Department of Medicine
Tel (603) 653-3881 | Fax (603) 650-0930
Dartmouth-Health.org
Dartmouth Hitchcock Medical Center
IMPORTANT NOTICE REGARDING THIS ELECTRONIC MESSAGE:
This message is intended for the use of the person to whom it is addressed and may contain information that is privileged, confidential, and protected from disclosure under applicable law. If you are not the intended recipient, your use of this message for
any purpose is strictly prohibited. If you have received this communication in error, please delete the message and notify the sender so that we may correct our records.
Reminder: This e-mail and any attachments are subject to the current HHC email retention policies. Please save or store appropriately in accordance with policy.